{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T14:13:48Z","timestamp":1770819228425,"version":"3.50.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,5,20]],"date-time":"2016-05-20T00:00:00Z","timestamp":1463702400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,5,20]],"date-time":"2016-05-20T00:00:00Z","timestamp":1463702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Transthyretin amyloidoses encompass a variety of acquired and hereditary diseases triggered by systemic extracellular accumulation of toxic transthyretin aggregates and fibrils, particularly in the peripheral nervous system. Since transthyretin amyloidoses are typically complex progressive disorders, therapeutic approaches aiming multiple molecular targets simultaneously, might improve therapy efficacy and treatment outcome. In this study, we evaluate the protective effect of physiologically achievable doses of curcumin on the cytotoxicity induced by transthyretin oligomers <jats:italic>in vitro<\/jats:italic> by showing reduction of caspase-3 activity and the levels of endoplasmic reticulum-resident chaperone binding immunoglobulin protein. When given to an aged Familial Amyloidotic Polyneuropathy mouse model, curcumin not only reduced transthyretin aggregates deposition and toxicity in both gastrointestinal tract and dorsal root ganglia but also remodeled congophilic amyloid material in tissues. In addition, curcumin enhanced internalization, intracellular transport and degradation of transthyretin oligomers by primary macrophages from aged Familial Amyloidotic Polyneuropathy transgenic mice, suggesting an impaired activation of na\u00efve phagocytic cells exposed to transthyretin toxic intermediate species. Overall, our results clearly support curcumin or optimized derivatives as promising multi-target disease-modifying agent for late-stage transthyretin amyloidosis.<\/jats:p>","DOI":"10.1038\/srep26623","type":"journal-article","created":{"date-parts":[[2016,5,21]],"date-time":"2016-05-21T09:30:01Z","timestamp":1463823001000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Curcumin: A multi-target disease-modifying agent for late-stage transthyretin amyloidosis"],"prefix":"10.1038","volume":"6","author":[{"given":"Nelson","family":"Ferreira","sequence":"first","affiliation":[]},{"given":"N\u00e1dia P.","family":"Gon\u00e7alves","sequence":"additional","affiliation":[]},{"given":"Maria J.","family":"Saraiva","sequence":"additional","affiliation":[]},{"given":"Maria R.","family":"Almeida","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2016,5,20]]},"reference":[{"key":"BFsrep26623_CR1","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1073\/pnas.83.2.503","volume":"83","author":"DA Kirschner","year":"1986","unstructured":"Kirschner, D. A., Abraham, C. & Selkoe, D. J. X-ray diffraction from intraneuronal paired helical filaments and extraneuronal amyloid fibers in Alzheimer disease indicates cross-beta conformation. Proc. Natl. Acad. Sci. USA 83, 503\u2013507 (1986).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFsrep26623_CR2","doi-asserted-by":"crossref","first-page":"12243","DOI":"10.1073\/pnas.91.25.12243","volume":"91","author":"A Lorenzo","year":"1994","unstructured":"Lorenzo, A. & Yankner, B. A. Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red. Proc. Natl. Acad. Sci. USA 91, 12243\u201312247 (1994).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFsrep26623_CR3","doi-asserted-by":"crossref","first-page":"6011","DOI":"10.1523\/JNEUROSCI.1189-06.2006","volume":"26","author":"A Deshpande","year":"2006","unstructured":"Deshpande, A., Mina, E., Glabe, C. & Busciglio, J. Different conformations of amyloid beta induce neurotoxicity by distinct mechanisms in human cortical neurons. J. Neurosci. 26, 6011\u20136018 (2006).","journal-title":"J. Neurosci."},{"key":"BFsrep26623_CR4","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.2174\/092986712800269236","volume":"19","author":"MJ Saraiva","year":"2012","unstructured":"Saraiva, M. J., Magalhaes, J., Ferreira, N. & Almeida, M. R. Transthyretin deposition in familial amyloidotic polyneuropathy. Curr. Med. Chem. 19, 2304\u20132311 (2012).","journal-title":"Curr. Med. Chem."},{"key":"BFsrep26623_CR5","doi-asserted-by":"crossref","first-page":"7576","DOI":"10.1523\/JNEUROSCI.21-19-07576.2001","volume":"21","author":"MM Sousa","year":"2001","unstructured":"Sousa, M. M. et al. Familial amyloid polyneuropathy: receptor for advanced glycation end products-dependent triggering of neuronal inflammatory and apoptotic pathways. J. Neurosci. 21, 7576\u20137586 (2001).","journal-title":"J. Neurosci."},{"key":"BFsrep26623_CR6","doi-asserted-by":"crossref","first-page":"21998","DOI":"10.1074\/jbc.M602302200","volume":"281","author":"PF Teixeira","year":"2006","unstructured":"Teixeira, P. F., Cerca, F., Santos, S. D. & Saraiva, M. J. Endoplasmic reticulum stress associated with extracellular aggregates. Evidence from transthyretin deposition in familial amyloid polyneuropathy. J. Biol. Chem. 281, 21998\u201322003 (2006).","journal-title":"J. Biol. Chem."},{"key":"BFsrep26623_CR7","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1096\/fj.04-2022fje","volume":"19","author":"MM Sousa","year":"2005","unstructured":"Sousa, M. M., do Amaral, J. B., Guimar\u00e3es, A. & Saraiva, M. J. Up-regulation of the extracellular matrix remodeling genes, biglycan, neutrophil gelatinase-associated lipocalin and matrix metalloproteinase-9 in familial amyloid polyneuropathy. FASEB J. 19, 124\u2013126 (2005).","journal-title":"FASEB J."},{"key":"BFsrep26623_CR8","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.neurobiolaging.2008.04.001","volume":"31","author":"SD Santos","year":"2010","unstructured":"Santos, S. D., Fernandes, R. & Saraiva, M. J. The heat shock response modulates transthyretin deposition in the peripheral and autonomic nervous systems. Neurobiol. Aging. 31, 280\u2013289 (2010).","journal-title":"Neurobiol. Aging."},{"key":"BFsrep26623_CR9","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1212\/01.WNL.0000132966.36437.12","volume":"63","author":"H Koike","year":"2004","unstructured":"Koike, H. et al. Pathology of early- vs late-onset TTR Met30 familial amyloid polyneuropathy. Neurology. 63, 129\u2013138 (2004).","journal-title":"Neurology."},{"key":"BFsrep26623_CR10","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1136\/postgradmedj-2014-133224","volume":"91","author":"S Dubrey","year":"2015","unstructured":"Dubrey, S., Ackermann, E. & Gillmore, J. The transthyretin amyloidoses: advances in therapy. Postgrad. Med. J. 91, 439\u2013448 (2015).","journal-title":"Postgrad. Med. J."},{"key":"BFsrep26623_CR11","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1016\/j.febslet.2009.10.062","volume":"583","author":"N Ferreira","year":"2009","unstructured":"Ferreira, N. et al. Binding of epigallocatechin-3-gallate to transthyretin modulates its amyloidogenicity. FEBS Lett. 583, 3569\u20133576 (2009).","journal-title":"FEBS Lett."},{"key":"BFsrep26623_CR12","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1016\/j.febslet.2011.06.030","volume":"585","author":"N Ferreira","year":"2011","unstructured":"Ferreira, N., Saraiva, M. J. & Almeida, M. R. Natural polyphenols inhibit different steps of the process of transthyretin (TTR) amyloid fibril formation. FEBS Lett. 585, 2424\u20132430 (2011).","journal-title":"FEBS Lett."},{"key":"BFsrep26623_CR13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.bbadis.2012.10.007","volume":"1832","author":"N Ferreira","year":"2013","unstructured":"Ferreira, N., Santos, S. A., Domingues, M. R., Saraiva, M. J. & Almeida, M. R. Dietary curcumin counteracts extracellular transthyretin deposition: insights on the mechanism of amyloid inhibition. Biochim. Biophys. Acta. 1832, 39\u201345 (2013).","journal-title":"Biochim. Biophys. Acta."},{"key":"BFsrep26623_CR14","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1021\/cn3001203","volume":"4","author":"PK Singh","year":"2013","unstructured":"Singh, P. K. et al. Curcumin modulates \u03b1-synuclein aggregation and toxicity. ACS Chem. Neurosci. 4, 393\u2013407 (2013).","journal-title":"ACS Chem. Neurosci."},{"key":"BFsrep26623_CR15","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1021\/acschemneuro.5b00214","volume":"7","author":"A Thapa","year":"2016","unstructured":"Thapa, A., Jett, S. D. & Chi, E. Y. Curcumin Attenuates Amyloid-\u03b2 Aggregate Toxicity and Modulates Amyloid-\u03b2 Aggregation Pathway. ACS Chem. Neurosci. 7, 56\u201368 (2016).","journal-title":"ACS Chem. Neurosci."},{"key":"BFsrep26623_CR16","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-0-387-46401-5_3","volume":"595","author":"VP Menon","year":"2007","unstructured":"Menon, V. P. & Sudheer, A. R. Antioxidant and anti-inflammatory properties of curcumin. Adv. Exp. Med. Biol. 595, 105\u2013125 (2007).","journal-title":"Adv. Exp. Med. Biol."},{"key":"BFsrep26623_CR17","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3233\/JAD-2004-6403","volume":"6","author":"L Baum","year":"2004","unstructured":"Baum, L. & Ng, A. Curcumin interaction with copper and iron suggests one possible mechanism of action in Alzheimer\u2019s disease animal models. J. Alzheimers Dis. 6, 367\u2013377 (2004).","journal-title":"J. Alzheimers Dis."},{"key":"BFsrep26623_CR18","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1212\/WNL.57.6.985","volume":"57","author":"V Chandra","year":"2001","unstructured":"Chandra, V. et al. Incidence of Alzheimer\u2019s disease in a rural community in India: the Indo-US study. Neurology 57, 985\u2013989 (2001).","journal-title":"Neurology"},{"key":"BFsrep26623_CR19","doi-asserted-by":"crossref","first-page":"12849","DOI":"10.1073\/pnas.0701267104","volume":"104","author":"M Fiala","year":"2007","unstructured":"Fiala, M. et al. Innate immunity and transcription of MGAT-III and Toll-like receptors in Alzheimer\u2019s disease patients are improved by bisdemethoxycurcumin. Proc. Natl. Acad. Sci. USA 104, 12849\u201312854 (2007).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFsrep26623_CR20","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ymeth.2004.10.010","volume":"35","author":"AS Lee","year":"2005","unstructured":"Lee, A. S. The ER chaperone and signaling regulator GRP78\/BiP as a monitor of endoplasmic reticulum stress. Methods 35, 373\u2013381 (2005).","journal-title":"Methods"},{"key":"BFsrep26623_CR21","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1177\/13.8.693","volume":"13","author":"H Puchtler","year":"1965","unstructured":"Puchtler, H. & Sweat, F. Congo red as a stain for fluorescence microscopy of amyloid. J. Histochem. Cytochem. 13, 693\u2013694 (1965).","journal-title":"J. Histochem. Cytochem."},{"key":"BFsrep26623_CR22","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.bbadis.2008.05.005","volume":"1782","author":"B Macedo","year":"2008","unstructured":"Macedo, B., Batista, A. R., Ferreira, N., Almeida, M. R. & Saraiva, M. J. Anti-apoptotic treatment reduces transthyretin deposition in a transgenic mouse model of Familial Amyloidotic Polyneuropathy. Biochim. Biophys. Acta. 1782, 517\u2013522 (2008).","journal-title":"Biochim. Biophys. Acta."},{"key":"BFsrep26623_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JAD-2006-10101","volume":"10","author":"L Zhang","year":"2006","unstructured":"Zhang, L. et al. Curcuminoids enhance amyloid-beta uptake by macrophages of Alzheimer\u2019s disease patients. J. Alzheimers Dis. 10, 1\u20137 (2006).","journal-title":"J. Alzheimers Dis."},{"key":"BFsrep26623_CR24","doi-asserted-by":"crossref","first-page":"192","DOI":"10.2174\/187152710791012044","volume":"9","author":"M Fiala","year":"2010","unstructured":"Fiala, M. Re-balancing of inflammation and abeta immunity as a therapeutic for Alzheimer\u2019s disease-view from the bedside. CNS Neurol. Disord. Drug. Targets 9, 192\u2013196 (2010).","journal-title":"CNS Neurol. Disord. Drug. Targets"},{"key":"BFsrep26623_CR25","doi-asserted-by":"crossref","first-page":"5631","DOI":"10.1016\/j.febslet.2005.09.032","volume":"579","author":"W Khazen","year":"2005","unstructured":"Khazen, W. et al. Expression of macrophage-selective markers in human and rodent adipocytes. FEBS Lett. 579, 5631\u20135634 (2005).","journal-title":"FEBS Lett."},{"key":"BFsrep26623_CR26","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.expneurol.2014.04.030","volume":"257","author":"NP Gon\u00e7alves","year":"2014","unstructured":"Gon\u00e7alves, N. P., Teixeira-Coelho, M. & Saraiva, M. J. The inflammatory response to sciatic nerve injury in a familial amyloidotic polyneuropathy mouse model. Exp. Neurol. 257, 76\u201387 (2014).","journal-title":"Exp. Neurol."},{"key":"BFsrep26623_CR27","doi-asserted-by":"crossref","first-page":"6111","DOI":"10.1021\/jm0607193","volume":"49","author":"EK Ryu","year":"2006","unstructured":"Ryu, E. K., Choe, Y. S., Lee, K. H., Choi, Y. & Kim, B. T. Curcumin and dehydrozingerone derivatives: synthesis, radiolabeling and evaluation for beta-amyloid plaque imaging. J. Med. Chem. 49, 6111\u20136119 (2006).","journal-title":"J. Med. Chem."},{"key":"BFsrep26623_CR28","doi-asserted-by":"crossref","first-page":"5892","DOI":"10.1074\/jbc.M404751200","volume":"280","author":"F Yang","year":"2005","unstructured":"Yang, F. et al. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques and reduces amyloid in vivo. J. Biol. Chem. 280, 5892\u20135901 (2005).","journal-title":"J. Biol. Chem."},{"key":"BFsrep26623_CR29","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.nbt.2014.09.002","volume":"32","author":"L Ciccone","year":"2015","unstructured":"Ciccone, L., Tepshi, L., Nencetti, S. & Stura, E. A. Transthyretin complexes with curcumin and bromo-estradiol: evaluation of solubilizing multicomponent mixtures. N Biotechnol. 32, 54\u201364 (2015).","journal-title":"N Biotechnol."},{"key":"BFsrep26623_CR30","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/2047-9158-3-19","volume":"3","author":"M Ueda","year":"2014","unstructured":"Ueda, M. & Ando, Y. Recent advances in transthyretin amyloidosis therapy. Transl Neurodegener 3, 19 (2014).","journal-title":"Transl Neurodegener"},{"key":"BFsrep26623_CR31","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1111\/j.1471-4159.2007.04613.x","volume":"102","author":"M Garcia-Alloza","year":"2007","unstructured":"Garcia-Alloza, M., Borrelli, L. A., Rozkalne, A., Hyman, B. T. & Bacskai, B. J. Curcumin labels amyloid pathology in vivo, disrupts existing plaques and partially restores distorted neurites in an Alzheimer mouse model. J. Neurochem. 102, 1095\u20131104 (2007).","journal-title":"J. Neurochem."},{"key":"BFsrep26623_CR32","doi-asserted-by":"crossref","first-page":"9123","DOI":"10.1021\/bi700607z","volume":"46","author":"LE Wilkinson-White","year":"2007","unstructured":"Wilkinson-White, L. E. & Easterbrook-Smith, S. B. Characterization of the binding of Cu(II) and Zn(II) to transthyretin: effects on amyloid formation. Biochemistry 46, 9123\u20139132 (2007).","journal-title":"Biochemistry"},{"key":"BFsrep26623_CR33","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1111\/bph.12131","volume":"169","author":"BB Aggarwal","year":"2013","unstructured":"Aggarwal, B. B., Gupta, S. C. & Sung, B. Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkers. Br. J. Pharmacol. 169, 1672\u20131692 (2013).","journal-title":"Br. J. Pharmacol."},{"key":"BFsrep26623_CR34","first-page":"112","volume":"8","author":"I Morales","year":"2014","unstructured":"Morales, I., Guzm\u00e1n-Mart\u00ednez, L., Cerda-Troncoso, C., Far\u00edas, G. A. & Maccioni, R. B. Neuroinflammation in the pathogenesis of Alzheimer\u2019s disease. A rational framework for the search of novel therapeutic approaches. Front. Cell. Neurosci. 8, 112 (2014).","journal-title":"Front. Cell. Neurosci."},{"key":"BFsrep26623_CR35","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/BF02708432","volume":"28","author":"M Balasubramanyam","year":"2003","unstructured":"Balasubramanyam, M. et al. Curcumin-induced inhibition of cellular reactive oxygen species generation: novel therapeutic implications. J. Biosci. 28, 715\u2013721 (2003).","journal-title":"J. Biosci."},{"key":"BFsrep26623_CR36","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1196\/annals.1338.057","volume":"1042","author":"WH Chan","year":"2005","unstructured":"Chan, W. H., Wu, H. J. & Hsuuw, Y. D. Curcumin inhibits ROS formation and apoptosis in methylglyoxal-treated human hepatoma G2 cells. Ann. N. Y. Acad. Sci. 1042, 372\u2013378 (2005).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"BFsrep26623_CR37","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.canlet.2015.05.017","volume":"365","author":"A Jain","year":"2015","unstructured":"Jain, A. et al. Curcumin inhibits PhIP induced cytotoxicity in breast epithelial cells through multiple molecular targets. Cancer Lett. 365, 122\u2013131 (2015).","journal-title":"Cancer Lett."},{"key":"BFsrep26623_CR38","doi-asserted-by":"publisher","first-page":"15017","DOI":"10.1038\/cddiscovery.2015.17","volume":"1","author":"A Moustapha","year":"2015","unstructured":"Moustapha, A. et al. Curcumin induces crosstalk between autophagy and apoptosis mediated by calcium release from the endoplasmic reticulum, lysosomal destabilization and mitochondrial events. Cell Death Discovery 1, 15017, doi: 10.1038\/cddiscovery.2015.17 (2015).","journal-title":"Cell Death Discovery"},{"key":"BFsrep26623_CR39","first-page":"6:e2003","volume":"3","author":"N Rainey","year":"2015","unstructured":"Rainey, N., Motte, L., Aggarwal, B. B. & Petit. P. X. Curcumin hormesis mediates a cross-talk between autophagy and cell death. Cell Death Dis 3, 6:e2003 (2015).","journal-title":"Cell Death Dis"},{"key":"BFsrep26623_CR40","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1161\/CIRCRESAHA.112.268946","volume":"111","author":"L Galluzzi","year":"2012","unstructured":"Galluzzi, L., Kepp, O., Trojel-Hansen, C. & Kroemer, G. Mitochondrial control of cellular life, stress and death. Circ. Res. 111, 1198\u20131207 (2012).","journal-title":"Circ. Res."},{"key":"BFsrep26623_CR41","first-page":"2121","volume":"8","author":"H Li","year":"2012","unstructured":"Li, H. et al. Curcumin could reduce the monomer of TTR with Tyr114Cys mutation via autophagy in cell model of familial amyloid polyneuropathy. Drug Des. Devel. Ther. 8, 2121\u20132128 (2012).","journal-title":"Drug Des. Devel. Ther."},{"key":"BFsrep26623_CR42","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/SHK.0000000000000118","volume":"41","author":"Z Tong","year":"2014","unstructured":"Tong, Z. et al. HSF-1 is involved in attenuating the release of inflammatory cytokines induced by LPS through regulating autophagy. Shock. 41, 449\u2013453 (2014).","journal-title":"Shock."},{"key":"BFsrep26623_CR43","doi-asserted-by":"crossref","first-page":"38176","DOI":"10.1074\/jbc.M002886200","volume":"275","author":"MM Sousa","year":"2000","unstructured":"Sousa, M. M. et al. Evidence for the role of megalin in renal uptake of transthyretin. J. Biol. Chem. 275, 38176\u201338181 (2000).","journal-title":"J. Biol. Chem."},{"key":"BFsrep26623_CR44","doi-asserted-by":"crossref","first-page":"14420","DOI":"10.1074\/jbc.M010869200","volume":"276","author":"MM Sousa","year":"2001","unstructured":"Sousa, M. M. & Saraiva, M. J. Internalization of transthyretin. Evidence of a novel yet unidentified receptor-associated protein (RAP)-sensitive receptor. J. Biol. Chem. 276, 14420\u201314425 (2001).","journal-title":"J. Biol. Chem."},{"key":"BFsrep26623_CR45","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1523\/JNEUROSCI.6012-08.2009","volume":"29","author":"CE Fleming","year":"2009","unstructured":"Fleming, C. E., Mar, F. M., Franquinho, F., Saraiva, M. J. & Sousa, M. M. Transthyretin internalization by sensory neurons is megalin mediated and necessary for its neuritogenic activity. J. Neurosci. 29, 3220\u20133232 (2009).","journal-title":"J. Neurosci."},{"key":"BFsrep26623_CR46","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s40478-014-0177-8","volume":"2","author":"NP Gon\u00e7alves","year":"2014","unstructured":"Gon\u00e7alves, N. P., Costelha, S. & Saraiva, M. J. Glial cells in familial amyloidotic polyneuropathy. Acta Neuropathol. Commun. 2, 177 (2014).","journal-title":"Acta Neuropathol. Commun"},{"key":"BFsrep26623_CR47","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/labinvest.2013.83","volume":"93","author":"Y Misumi","year":"2013","unstructured":"Misumi, Y., Ando, Y., Gon\u00e7alves, N. P. & Saraiva, M. J. Fibroblasts endocytose and degrade transthyretin aggregates in transthyretin-related amyloidosis. Lab. Invest. 93, 911\u2013920 (2013).","journal-title":"Lab. Invest."},{"key":"BFsrep26623_CR48","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1021\/bi00223a017","volume":"30","author":"H Furuya","year":"1991","unstructured":"Furuya, H. et al. Production of recombinant human transthyretin with biological activities toward the understanding of the molecular basis of familial amyloidotic polyneuropathy (FAP). Biochemistry. 30, 2415\u20132421 (1991).","journal-title":"Biochemistry."},{"key":"BFsrep26623_CR49","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1042\/BJ20040011","volume":"381","author":"MR Almeida","year":"2004","unstructured":"Almeida, M. R. et al. Selective binding to transthyretin and tetramer stabilization in serum from patients with familial amyloidotic polyneuropathy by an iodinated diflunisal derivative. Biochem. J. 381, 351\u2013356 (2004).","journal-title":"Biochem. J."},{"key":"BFsrep26623_CR50","doi-asserted-by":"crossref","first-page":"e29933","DOI":"10.1371\/journal.pone.0029933","volume":"7","author":"N Ferreira","year":"2012","unstructured":"Ferreira, N., Saraiva, M. J. & Almeida, M. R. Epigallocatechin-3-gallate as a potential therapeutic drug for TTR-related amyloidosis: \u201cin vivo\u201d evidence from FAP mice models. PLos One. 7, e29933 (2012).","journal-title":"PLos One."},{"key":"BFsrep26623_CR51","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.4049\/jimmunol.1401088","volume":"193","author":"FW McNab","year":"2014","unstructured":"McNab, F. W. et al. Type I IFN induces IL-10 production in an IL-27-independent manner and blocks responsiveness to IFN-\u03b3 for production of IL-12 and bacterial killing in Mycobacterium tuberculosis-infected macrophages. J. Immunol. 193, 3600\u20133612 (2014).","journal-title":"J. Immunol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep26623","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep26623.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep26623.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T14:47:21Z","timestamp":1672843641000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep26623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,20]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,7,18]]}},"alternative-id":["BFsrep26623"],"URL":"https:\/\/doi.org\/10.1038\/srep26623","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,20]]},"assertion":[{"value":"1 December 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26623"}}